Prime Medicine (PRME) Interest & Investment Income (2023 - 2026)

Prime Medicine (PRME) has 4 years of Interest & Investment Income data on file, last reported at $1.0 million in Q1 2026.

• Quarterly Interest & Investment Income fell 13.62% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.0 million (down 0.99% YoY) and the FY2025 annual result came in at $4.1 million, up 17.8% from the prior year.
• Interest & Investment Income declined to $1.0 million in Q1 2026, from $1.1 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $1.5 million in Q4 2024 to a low of $410000.0 in Q3 2023.
• A 4-year average of $852333.3 and a median of $720000.0 in 2024 frame the typical range for Interest & Investment Income.
• Annual changes were most pronounced in 2024 — Interest & Investment Income surged 213.24% — and 2025, when it declined 29.58%.
• Tracing PRME's Interest & Investment Income over 4 years: stood at $491000.0 in 2023, then surged by 213.24% to $1.5 million in 2024, then decreased by 29.58% to $1.1 million in 2025, then fell by 5.72% to $1.0 million in 2026.
• The last three Interest & Investment Income figures came in at $1.0 million (Q1 2026), $1.1 million (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.